IL142069A0 - Methods of downmodulating the immune response to therapeutic proteins - Google Patents

Methods of downmodulating the immune response to therapeutic proteins

Info

Publication number: IL142069A0
Authority: IL; Israel
Prior art keywords: downmodulating; methods; immune response; therapeutic proteins; proteins
Prior art date: 1998-09-21

Application number

IL14206999A

Original Assignee

Genetics Inst

American Nat Red Cross

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-09-21

Filing date

1999-09-21

Publication date

2002-03-10

1999-09-21 Application filed by Genetics Inst, American Nat Red Cross filed Critical Genetics Inst

2002-03-10 Publication of IL142069A0 publication Critical patent/IL142069A0/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/37—Factors VIII
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Immunology (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Hematology (AREA)
General Chemical & Material Sciences (AREA)
Zoology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Microbiology (AREA)
Mycology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

IL14206999A 1998-09-21 1999-09-21 Methods of downmodulating the immune response to therapeutic proteins IL142069A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US15817898A	1998-09-21	1998-09-21
PCT/US1999/021991 WO2000016801A1 (en)	1998-09-21	1999-09-21	Methods of downmodulating the immune response to therapeutic proteins

Publications (1)

Publication Number	Publication Date
IL142069A0 true IL142069A0 (en)	2002-03-10

Family

ID=22566971

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL14206999A IL142069A0 (en)	1998-09-21	1999-09-21	Methods of downmodulating the immune response to therapeutic proteins

Country Status (21)

Country	Link
EP (1)	EP1115423A1 (en)
JP (1)	JP2002526455A (en)
KR (1)	KR20010085830A (en)
CN (1)	CN1331602A (en)
AU (1)	AU761206B2 (en)
BR (1)	BR9913991A (en)
CA (1)	CA2343916A1 (en)
CZ (1)	CZ20011021A3 (en)
EA (1)	EA005236B1 (en)
HK (1)	HK1039059A1 (en)
HU (1)	HUP0103960A3 (en)
IL (1)	IL142069A0 (en)
LT (1)	LT4920B (en)
LV (1)	LV12768B (en)
MX (1)	MXPA01002898A (en)
NO (1)	NO20011412L (en)
NZ (1)	NZ511034A (en)
PL (1)	PL346796A1 (en)
SI (1)	SI20626A (en)
WO (1)	WO2000016801A1 (en)
ZA (1)	ZA200103156B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5397703A (en)	1992-07-09	1995-03-14	Cetus Oncology Corporation	Method for generation of antibodies to cell surface molecules
EP1289552B1 (en) *	2000-05-19	2006-03-29	The Center for Blood Research, INC.	Methods for treating hemostatic disorders by soluble p-selectin
EP1636579A4 (en) *	2003-06-10	2011-10-05	Smiths Detection Inc	Sensor arrangement
GB201508024D0 (en) *	2015-05-11	2015-06-24	Haemostatix Ltd	Haemostatic compositions

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5171569A (en)	1985-03-15	1992-12-15	National Research Development Corporation	Factor IX preparations uncontaminated by plasma components or pox virus
ATE72838T1 (en)	1985-04-12	1992-03-15	Genetics Inst	NEW PROCOAGULATION PROTEINS.
US5422260A (en)	1986-05-29	1995-06-06	Genetics Institute, Inc. -Legal Affairs	Human factor VIII:c muteins
US4994371A (en)	1987-08-28	1991-02-19	Davie Earl W	DNA preparation of Christmas factor and use of DNA sequences
FR2657884B1 (en)	1990-02-05	1994-09-02	Tm Innovation	PROCESS FOR THE PREPARATION OF HUMAN FACTOR VIII AND FACTOR VIII ANALOGS.
US5661008A (en)	1991-03-15	1997-08-26	Kabi Pharmacia Ab	Recombinant human factor VIII derivatives
US5770197A (en)	1991-06-27	1998-06-23	Bristol-Myers Squibb Company	Methods for regulating the immune response using B7 binding molecules and IL4-binding molecules
EP0606217B2 (en)	1991-06-27	2008-12-03	Bristol-Myers Squibb Company	Ctl4a receptor, fusion proteins containing it and uses thereof
WO1993009804A1 (en)	1991-11-18	1993-05-27	The Scripps Research Institute	Serine protease derived-polypeptides and anti-peptide antibodies, systems and therapeutic methods for inhibiting coagulation
US5744446A (en)	1992-04-07	1998-04-28	Emory University	Hybrid human/animal factor VIII
US5663060A (en)	1992-04-07	1997-09-02	Emory University	Hybrid human/animal factor VIII
US5364771A (en)	1992-04-07	1994-11-15	Emory University	Hybrid human/porcine factor VIII
US5621039A (en)	1993-06-08	1997-04-15	Hallahan; Terrence W.	Factor IX- polymeric conjugates
EP0776217A1 (en) *	1994-08-19	1997-06-04	Novo Nordisk A/S	A method of treating a patient with a biologically active compound
EP0804076A4 (en) *	1994-10-19	1998-10-21	Genetic Therapy Inc	Gene therapy involving concurrent and repeated administration of adenoviruses and immunosuppressive agents
US5714583A (en)	1995-06-07	1998-02-03	Genetics Institute, Inc.	Factor IX purification methods
DE69713499T3 (en) *	1996-03-20	2010-05-06	Bristol-Myers Squibb Co., Seattle	PROCEDURE FOR INHIBITING THE IMMUNE REACTION BY BLOCKING THE GP39 / CD40 AND CTLA4 / CD28 / B7 ROUTES AND COMPOSITION TO THEIR USE
KR20000070035A (en) *	1997-01-10	2000-11-25	아스트루 마이클 제이	Methods Of Therapeutic Administration of Anti-CD40L Compounds
KR100567998B1 (en) *	1997-06-20	2006-04-07	바이오겐 아이덱 엠에이 인코포레이티드	CD154 blockade therapy for therapeutic protein inhibitor syndrome
US8099877B2 (en)	2009-11-06	2012-01-24	Hexagon Metrology Ab	Enhanced position detection for a CMM

1999
- 1999-09-21 IL IL14206999A patent/IL142069A0/en unknown
- 1999-09-21 EP EP99969339A patent/EP1115423A1/en not_active Withdrawn
- 1999-09-21 BR BR9913991-0A patent/BR9913991A/en not_active IP Right Cessation
- 1999-09-21 JP JP2000573762A patent/JP2002526455A/en not_active Withdrawn
- 1999-09-21 CA CA002343916A patent/CA2343916A1/en not_active Abandoned
- 1999-09-21 NZ NZ511034A patent/NZ511034A/en unknown
- 1999-09-21 AU AU60578/99A patent/AU761206B2/en not_active Ceased
- 1999-09-21 MX MXPA01002898A patent/MXPA01002898A/en unknown
- 1999-09-21 CN CN99813510A patent/CN1331602A/en active Pending
- 1999-09-21 SI SI9920084A patent/SI20626A/en not_active IP Right Cessation
- 1999-09-21 PL PL99346796A patent/PL346796A1/en not_active Application Discontinuation
- 1999-09-21 CZ CZ20011021A patent/CZ20011021A3/en unknown
- 1999-09-21 WO PCT/US1999/021991 patent/WO2000016801A1/en not_active Application Discontinuation
- 1999-09-21 HU HU0103960A patent/HUP0103960A3/en unknown
- 1999-09-21 EA EA200100385A patent/EA005236B1/en not_active IP Right Cessation
- 1999-09-21 KR KR1020017003611A patent/KR20010085830A/en not_active Application Discontinuation
2001
- 2001-03-20 NO NO20011412A patent/NO20011412L/en not_active Application Discontinuation
- 2001-04-18 ZA ZA200103156A patent/ZA200103156B/en unknown
- 2001-04-20 LV LVP-01-62A patent/LV12768B/en unknown
- 2001-04-20 LT LT2001045A patent/LT4920B/en not_active IP Right Cessation
2002
- 2002-01-10 HK HK02100157.7A patent/HK1039059A1/en unknown

Also Published As

Publication number	Publication date
NO20011412L (en)	2001-05-16
HUP0103960A3 (en)	2003-09-29
LV12768B (en)	2002-06-20
EA200100385A1 (en)	2001-10-22
MXPA01002898A (en)	2002-06-04
BR9913991A (en)	2001-07-03
AU761206B2 (en)	2003-05-29
WO2000016801A1 (en)	2000-03-30
NO20011412D0 (en)	2001-03-20
CZ20011021A3 (en)	2001-10-17
JP2002526455A (en)	2002-08-20
CN1331602A (en)	2002-01-16
KR20010085830A (en)	2001-09-07
LV12768A (en)	2001-12-20
CA2343916A1 (en)	2000-03-30
NZ511034A (en)	2004-03-26
AU6057899A (en)	2000-04-10
EA005236B1 (en)	2004-12-30
LT4920B (en)	2002-06-25
WO2000016801A9 (en)	2000-10-26
LT2001045A (en)	2002-01-25
ZA200103156B (en)	2002-07-18
EP1115423A1 (en)	2001-07-18
HUP0103960A2 (en)	2002-02-28
PL346796A1 (en)	2002-02-25
SI20626A (en)	2002-02-28
HK1039059A1 (en)	2002-04-12

Publication	Publication Date	Title
AP2000001983A0 (en)	2000-12-31	Antibodies to cd23 derivatives thereof and their therapeutic uses
IL132318A0 (en)	2001-03-19	Substituted imidazoles useful in the treatment of inflammatory diseases
ID28111A (en)	2001-05-03	METHODS TO IMPROVE SKIN HEALTH
IL135673A0 (en)	2001-05-20	Therapeutic uses of quinoline derivatives
EP1033994A4 (en)	2002-04-03	Methods of preparation of bioginkgo
FI964193A (en)	1996-12-18	Preparation of purines
ZA984174B (en)	1998-11-23	Novel triptolide derivatives useful in the treatment of autoimmune diseases
IL133089A0 (en)	2001-03-19	Novel triptolide derivatives useful in the treatment of autoimmune diseases
PL346796A1 (en)	2002-02-25	Methods of downmodulating the immune response to therapeutic proteins
IL141551A0 (en)	2002-03-10	Compositions and methods for the treatment of immune related diseases
FI953580A (en)	1996-01-27	Preparation of acyclovir
ID24759A (en)	2000-08-03	METHODS TO IMPROVE BONE VOLUME
GB9822619D0 (en)	1998-12-09	Immune response stimulation
GB2329384B (en)	2002-01-30	Preparation of 1-chloro-1-cyclopropylethene
GB9727230D0 (en)	1998-02-25	Improvements relating to adjustable furniture
GB9727410D0 (en)	1998-02-25	Improvements relating to adjustable furniture
KR960025637U (en)	1996-07-22	Easy to adjust connector
KR960019736U (en)	1996-07-18	Structure of the sole
NO965332D0 (en)	1996-12-12	Therapeutic preparation
GB9720509D0 (en)	1997-11-26	Improvements relating to furniture
TW315720U (en)	1997-09-11	Structure of treadmill also having the resupination function of human body
KR960013110U (en)	1996-05-17	Chiropractor easy to attach to the bottom of the shoe
GB9606255D0 (en)	1996-05-29	The game of bridge companion
TW322782U (en)	1997-12-11	Structure improvement of walker
TW351186U (en)	1999-01-21	Improvement of exercise walker